By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Institutes of Health wants to fund studies aimed at personalizing drug treatments for alcoholism by using pharmacogenomic approaches and research into how genetic variation affects drug reactions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.